Product Information

THYROID 30 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.5962 per EA under NDC 62559074101. Its NADAC has been published 118 times since May 22, 2024.

THYROID 30 MG TABLET

Thyroid
$0.5962per EA

Strength

30 mg/1

NDC

62559074101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

THYROID

Approval Type

Unapproved

On Market Since

6/15/2023

Price Statistics

The NADAC for THYROID 30 MG TABLET has been published 118 times since May 22, 2024, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5962 per EA
All-time high$0.6286 (Jul 10, 2024)
All-time low$0.5358 (Nov 20, 2024)
52-week high$0.6106
52-week low$0.5717
Median price$0.5913
Average price$0.5936
Largest weekly change-14.3% (Nov 20, 2024)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

+0.2%

1M

+0.2%

3M

+1.5%

6M

+1.3%

1Y

-2.4%

3Y

N/A

5Y

N/A

All

+7.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Thyroid market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of THYROID 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for THYROID 30 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.5962 per EA (NDC 62559074101), effective Aug 19, 2026.

How has the price of THYROID 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for THYROID 30 MG TABLET has risen 7.2%. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for THYROID 30 MG TABLET?

Since May 22, 2024, the NADAC for THYROID 30 MG TABLET has ranged from a low of $0.5358 (Nov 20, 2024) to a high of $0.6286 (Jul 10, 2024), with a median of $0.5913 per EA.

Are there cheaper alternatives to THYROID 30 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of THYROID 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures THYROID 30 MG TABLET?

THYROID 30 MG TABLET (NDC 62559074101) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.